Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spending
Novartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to slash its healthcare ...
Vas Narasimhan, Novartis CEO (Gian Ehrenzeller/Keystone via AP Images) April 28, 2026 06:35 AM EDTUpdated 01:44 PM Pharma Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spending Ayisha Sharma News Reporter Novartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that